FdaApplication

NDA 208385

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSAGENT PHARMACEUTICALS INC
application_typeNDA
approval_date2017-09-12

Products (1)

ProductActive ingredientStrengthDosage form
DAPTOMYCINDAPTOMYCIN350MG/VIALPOWDER;INTRAVENOUS

1 product